Pedro
Berraondo López
Profesional Investigador
Centro Nacional de Investigaciones Oncológicas
Madrid, EspañaPublications in collaboration with researchers from Centro Nacional de Investigaciones Oncológicas (2)
2023
-
Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution
Frontiers in Immunology, Vol. 14
2021
-
CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation
Nature Communications, Vol. 12, Núm. 1